These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34771087)

  • 21. Virtual Screening of
    Mizera M; Latek D; Cielecka-Piontek J
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3D-QSAR studies of arylpyrazole antagonists of cannabinoid receptor subtypes CB1 and CB2. A combined NMR and CoMFA approach.
    Chen JZ; Han XW; Liu Q; Makriyannis A; Wang J; Xie XQ
    J Med Chem; 2006 Jan; 49(2):625-36. PubMed ID: 16420048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal Structure of the Human Cannabinoid Receptor CB2.
    Li X; Hua T; Vemuri K; Ho JH; Wu Y; Wu L; Popov P; Benchama O; Zvonok N; Locke K; Qu L; Han GW; Iyer MR; Cinar R; Coffey NJ; Wang J; Wu M; Katritch V; Zhao S; Kunos G; Bohn LM; Makriyannis A; Stevens RC; Liu ZJ
    Cell; 2019 Jan; 176(3):459-467.e13. PubMed ID: 30639103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of estrogen receptor α ligands with virtual screening techniques.
    Niinivehmas SP; Manivannan E; Rauhamäki S; Huuskonen J; Pentikäinen OT
    J Mol Graph Model; 2016 Mar; 64():30-39. PubMed ID: 26774287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-Based Virtual Screening and Molecular Dynamics Simulation Assessments of Depsidones as Possible Selective Cannabinoid Receptor Type 2 Agonists.
    Mohamed GA; Omar AM; AlKharboush DF; Fallatah MA; Sindi IA; El-Agamy DS; Ibrahim SRM
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cryo-EM Structure of the Human Cannabinoid Receptor CB2-G
    Xing C; Zhuang Y; Xu TH; Feng Z; Zhou XE; Chen M; Wang L; Meng X; Xue Y; Wang J; Liu H; McGuire TF; Zhao G; Melcher K; Zhang C; Xu HE; Xie XQ
    Cell; 2020 Feb; 180(4):645-654.e13. PubMed ID: 32004460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of novel CB2 receptor ligands by a pharmacophore-based virtual screening workflow.
    Markt P; Feldmann C; Rollinger JM; Raduner S; Schuster D; Kirchmair J; Distinto S; Spitzer GM; Wolber G; Laggner C; Altmann KH; Langer T; Gertsch J
    J Med Chem; 2009 Jan; 52(2):369-78. PubMed ID: 19143566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.
    Brogi S; Corelli F; Di Marzo V; Ligresti A; Mugnaini C; Pasquini S; Tafi A
    Eur J Med Chem; 2011 Feb; 46(2):547-55. PubMed ID: 21183257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CB2-selective cannabinoid receptor ligands: synthesis, pharmacological evaluation, and molecular modeling investigation of 1,8-Naphthyridin-2(1H)-one-3-carboxamides.
    Lucchesi V; Hurst DP; Shore DM; Bertini S; Ehrmann BM; Allarà M; Lawrence L; Ligresti A; Minutolo F; Saccomanni G; Sharir H; Macchia M; Di Marzo V; Abood ME; Reggio PH; Manera C
    J Med Chem; 2014 Nov; 57(21):8777-91. PubMed ID: 25272206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling, molecular dynamics simulation, and mutation validation for structure of cannabinoid receptor 2 based on known crystal structures of GPCRs.
    Feng Z; Alqarni MH; Yang P; Tong Q; Chowdhury A; Wang L; Xie XQ
    J Chem Inf Model; 2014 Sep; 54(9):2483-99. PubMed ID: 25141027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, syntheses, structure-activity relationships and docking studies of coumarin derivatives as novel selective ligands for the CB2 receptor.
    Han S; Zhang FF; Qian HY; Chen LL; Pu JB; Xie X; Chen JZ
    Eur J Med Chem; 2015 Mar; 93():16-32. PubMed ID: 25644673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrating pharmacophore mapping, virtual screening, density functional theory, molecular simulation towards the discovery of novel apolipoprotein (apoE ε4) inhibitors.
    Johari S; Sharma A; Sinha S; Das A
    Comput Biol Chem; 2019 Apr; 79():83-90. PubMed ID: 30743160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabinoid Receptor Type II Ligands from Sandalwood Oil and Synthetic α-Santalol Derivatives.
    Paudel P; Pandey P; Paris JJ; Ashpole NM; Mahdi F; Tian JM; Lee J; Wang M; Xu M; Chittiboyina AG; Khan IA; Ross SA; Li XC
    J Nat Prod; 2023 Jul; 86(7):1786-1792. PubMed ID: 37450763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacophore-based virtual screening, biological evaluation and binding mode analysis of a novel protease-activated receptor 2 antagonist.
    Cho NC; Seo SH; Kim D; Shin JS; Ju J; Seong J; Seo SH; Lee I; Lee KT; Kim YK; No KT; Pae AN
    J Comput Aided Mol Des; 2016 Aug; 30(8):625-37. PubMed ID: 27600555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two Affinity Sites of the Cannabinoid Subtype 2 Receptor Identified by a Novel Homogeneous Binding Assay.
    Martínez-Pinilla E; Rabal O; Reyes-Resina I; Zamarbide M; Navarro G; Sánchez-Arias JA; de Miguel I; Lanciego JL; Oyarzabal J; Franco R
    J Pharmacol Exp Ther; 2016 Sep; 358(3):580-7. PubMed ID: 27358483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-Based Virtual Screening.
    Li Q; Shah S
    Methods Mol Biol; 2017; 1558():111-124. PubMed ID: 28150235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AI-based prediction of new binding site and virtual screening for the discovery of novel P2X3 receptor antagonists.
    Kang KM; Lee I; Nam H; Kim YC
    Eur J Med Chem; 2022 Oct; 240():114556. PubMed ID: 35849939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of novel cannabinoid receptor ligands by a virtual screening approach: further development of 2,4,6-trisubstituted 1,3,5-triazines as CB2 agonists.
    Yrjölä S; Kalliokoski T; Laitinen T; Poso A; Parkkari T; Nevalainen T
    Eur J Pharm Sci; 2013 Jan; 48(1-2):9-20. PubMed ID: 23131798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, Synthesis, and SAR Studies of Heteroarylpyrimidines and Heteroaryltriazines as CB
    Qian HY; Wang ZL; Chen LL; Pan YL; Xie XY; Xie X; Chen JZ
    ChemMedChem; 2018 Nov; 13(22):2455-2463. PubMed ID: 30246417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.